BNGO

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.04
Percentage change 1.05	%

Peers: ILMN PACB CDNA FLGT QGEN MYGN TWST ONC GH TXG

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-57.26	Insider Own	0.36%	Shs Outstand	3.36M	Perf Week	1.67%
Market Cap	11.29M	Forward P/E	-	EPS next Y	-4.07	Insider Trans	0.00%	Shs Float	3.35M	Perf Month	-10.53%
Enterprise Value	0.47M	PEG	-	EPS next Q	-2.42	Inst Own	9.13%	Short Float	16.39%	Perf Quarter	13.73%
Income	-83.70M	P/S	0.40	EPS this Y	91.78%	Inst Trans	-54.93%	Short Ratio	4.01	Perf Half Y	-82.34%
Sales	28.46M	P/B	0.22	EPS next Y	43.85%	ROA	-70.81%	Short Interest	0.55M	Perf YTD	-80.61%
Book/sh	15.54	P/C	0.39	EPS next 5Y	75.04%	ROE	-127.82%	52W High	41.33 -91.88%	Perf Year	-89.81%
Cash/sh	8.69	P/FCF	-	EPS past 3/5Y	17.51% 40.63%	ROIC	-161.85%	52W Low	2.68 25.19%	Perf 3Y	-99.58%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	19.62% 24.89%	Gross Margin	1.74%	Volatility	4.53% 4.88%	Perf 5Y	-99.02%
Dividend TTM	-	EV/Sales	0.02	EPS Y/Y TTM	84.11%	Oper. Margin	-237.66%	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.34	Sales Y/Y TTM	-24.04%	Profit Margin	-294.05%	RSI (14)	44.23	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.70	EPS Q/Q	96.78%	SMA20	-1.04%	Beta	2.07	Target Price	7.33
Payout	-	Debt/Eq	0.38	Sales Q/Q	-26.37%	SMA50	-7.97%	Rel Volume	0.42	Prev Close	3.32
Employees	100	LT Debt/Eq	0.07	Earnings	May 14 AMC	SMA200	-65.45%	Avg Volume	136.95K	Price	3.36
IPO	Sep 21, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	61.94% 3.31%	Trades		Volume	56,680	Change	1.05%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Downgrade	Ladenburg Thalmann	Buy → Neutral
Sep-10-24	Downgrade	BTIG Research	Buy → Neutral
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$4
Dec-12-22	Resumed	BTIG Research	Buy	$3.50
Jul-18-22	Resumed	Oppenheimer	Outperform	$12
Jun-16-21	Initiated	BTIG Research	Buy	$10
Sep-24-20	Initiated	Ladenburg Thalmann	Buy	$1.25
Apr-08-20	Initiated	Oppenheimer	Outperform	$1.50

Jun-18-25 08:00AM	Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy (GlobeNewswire)
May-15-25 07:43AM	Q1 2025 Bionano Genomics Inc Earnings Call (Thomson Reuters StreetEvents) +5.08%
03:16AM	Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
May-14-25 04:01PM	Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress (GlobeNewswire) -5.32%
May-13-25 05:30PM	Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Loading…
May-07-25 04:01PM	Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 (GlobeNewswire)
May-02-25 09:30AM	International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers (GlobeNewswire)
Apr-23-25 08:00AM	Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease (GlobeNewswire)
Apr-08-25 08:00AM	Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM (GlobeNewswire)
Apr-01-25 12:26PM	Q4 2024 Bionano Genomics Inc Earnings Call (Thomson Reuters StreetEvents) +11.11%
03:04AM	Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... (GuruFocus.com)
Mar-31-25 08:30PM	Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript (Motley Fool)
08:11PM	Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript (Seeking Alpha)
04:01PM	Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 (GlobeNewswire)
Mar-24-25 08:00AM	Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect (GlobeNewswire)
08:00AM	Loading…
Mar-18-25 08:00AM	Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting (GlobeNewswire) -5.19%
Mar-14-25 08:00AM	Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 (GlobeNewswire)
Mar-13-25 09:00AM	Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML (GlobeNewswire) -8.03%
Jan-22-25 04:05PM	Bionano Announces Effective Date of Reverse Stock Split (GlobeNewswire) -28.68%
Jan-14-25 08:00AM	Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss (GlobeNewswire) -7.94%
Jan-13-25 08:00AM	Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results (GlobeNewswire)
Jan-07-25 08:00AM	Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia (GlobeNewswire)
07:30AM	BioNano Genomics Announces $10 Million Direct Offering (TipRanks)
Jan-06-25 04:30PM	Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire) -11.68%
Jan-03-25 02:34PM	Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire) +24.05%
Dec-31-24 03:26PM	Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway (GlobeNewswire)
Dec-23-24 08:30AM	Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis (GlobeNewswire)
Dec-19-24 08:00AM	Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal (GlobeNewswire)
Dec-10-24 08:00AM	Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell and Gene Therapy (GlobeNewswire) -5.96%
08:00AM	Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy (GlobeNewswire)
02:15AM	Loading…
Nov-14-24 02:15AM	Bionano Genomics Inc (BNGO) Q3 2024 Earnings Call Highlights: Strategic Shifts Amid Revenue ... (GuruFocus.com) -7.58%
Nov-13-24 08:45PM	Bionano Genomics (BNGO) Q3 2024 Earnings Call Transcript (Motley Fool)
04:01PM	Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress (GlobeNewswire)
Nov-07-24 04:01PM	Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 (GlobeNewswire) -5.26%
Oct-31-24 04:30PM	Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire) -14.49%
08:10AM	Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 (GlobeNewswire)
08:00AM	Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules (GlobeNewswire)
Oct-24-24 08:00AM	Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma (GlobeNewswire)
Oct-10-24 08:00AM	Bionano Announces Preliminary 3Q 2024 Revenues and Cash (GlobeNewswire) -11.99%
Oct-09-24 05:18PM	Bionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Oct-03-24 08:00AM	Bionano Adjourns Special Meeting of Stockholders to October 30, 2024 (GlobeNewswire)
Sep-06-24 09:55AM	Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now (Zacks)
Sep-04-24 08:00AM	Bionano to Present at the H.C. Wainwright 26 Annual Global Investment Conference (GlobeNewswire)
Aug-13-24 12:00PM	Bionano Genomics (BNGO) Upgraded to Buy: Here's Why (Zacks) +8.87%
Aug-08-24 12:15AM	Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript (Motley Fool) -6.72%
Aug-07-24 11:53PM	BNGO Stock Earnings: Bionano Genomics Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace) -15.88%
04:01PM	Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress (GlobeNewswire)
Aug-01-24 08:00AM	Bionano Announces Presentation of Optical Genome Mapping Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2024 Annual Meeting (GlobeNewswire) -8.45%
Jul-31-24 04:01PM	Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
08:00AM	Bionano to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 7, 2024 (GlobeNewswire)
Jul-23-24 08:00AM	Bionano Announces Publication of First Multi-Site Study to Analyze the Utility of OGM in Multiple Myeloma (GlobeNewswire)
Jul-16-24 06:30AM	3 Quantum AI Stocks That Could Redefine Computing (InvestorPlace) +5.14%
Jul-08-24 05:25PM	Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) +12.68%
Jul-05-24 08:00AM	Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Jul-02-24 08:00AM	Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations (GlobeNewswire) -13.91%
08:00AM	Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting (GlobeNewswire)
Jun-20-24 08:00AM	Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research (GlobeNewswire)
Jun-17-24 04:05PM	Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis (GlobeNewswire)
May-30-24 08:00AM	Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow (GlobeNewswire)
May-28-24 02:01PM	3 Sorry Healthcare Stocks to Sell in May While You Still Can (InvestorPlace)
08:00AM	Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet (GlobeNewswire)
May-21-24 08:00AM	Bionano Announces Three Publications Demonstrating OGM's Utility for Cell and Gene Therapy (GlobeNewswire)
May-10-24 08:00AM	The 3 Best Healthcare Stocks to Buy in May 2024 (InvestorPlace)
May-09-24 12:08PM	Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2024 Earnings Call Transcript (Insider Monkey) +6.79%
08:00AM	Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis (GlobeNewswire)
06:03AM	Q1 2024 Bionano Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
03:44AM	Bionano Genomics Inc (BNGO) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ... (GuruFocus.com)
May-08-24 08:58PM	BNGO Stock Earnings: Bionano Genomics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:30PM	Bionano Genomics (BNGO) Q1 2024 Earnings Call Transcript (Motley Fool)
04:01PM	Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress (GlobeNewswire)
May-01-24 08:00AM	Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024 (GlobeNewswire) +8.54%
Apr-30-24 04:05PM	Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference (GlobeNewswire)
Apr-25-24 01:10PM	3 Contrarian Investments to Make Now for Massive Upside Potential (InvestorPlace)
Apr-24-24 08:00AM	Bionano Announces Publication Showing OGM's High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing (GlobeNewswire)
Apr-17-24 08:00AM	Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence (GlobeNewswire)
Apr-11-24 08:00AM	Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing (GlobeNewswire)
Apr-04-24 01:44PM	Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Apr-03-24 08:00AM	Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics (GlobeNewswire)
Apr-02-24 08:00AM	Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys System at the American Association for Cancer Research Annual Meeting (GlobeNewswire) -6.78%
Mar-19-24 08:00AM	Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance (GlobeNewswire)
Mar-07-24 11:47AM	Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:00AM	Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys System (GlobeNewswire)
Mar-06-24 06:44AM	Q4 2023 Bionano Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
12:30AM	Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript (Motley Fool)
Mar-05-24 11:51PM	BNGO Stock Earnings: Bionano Genomics Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
04:01PM	Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 (GlobeNewswire)
Feb-29-24 08:00AM	Bionano to Present at TD Cowen's 44th Annual Health Care Conference (GlobeNewswire)
Feb-28-24 08:01AM	Bionano to Report Fourth Quarter and Year End 2023 Financial Results and Host a Conference Call and Webcast on March 5, 2024 (GlobeNewswire)
08:00AM	Bionano Announces Amendment to Debt Financing Arrangement to Extend Cash Runway (GlobeNewswire)
Feb-22-24 08:00AM	American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis (GlobeNewswire)
Feb-07-24 01:10PM	7 Penny Stocks to Buy on the Dip: February 2024 (InvestorPlace)
Jan-31-24 08:00AM	Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -5.60%
Jan-30-24 08:00AM	Bionanos Symposium 2024 Featured Presentations from its Global User Community Highlighting OGM as a Powerful Alternative to Classical Cytogenetics and Strong Complement to NGS (GlobeNewswire)
Jan-25-24 08:00AM	Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer (GlobeNewswire)
Jan-24-24 08:00AM	Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing (GlobeNewswire) -6.06%
Jan-23-24 08:00AM	Bionano Announces Full Commercial Release of the Stratys System for High Throughput Optical Genome Mapping (GlobeNewswire)
Jan-19-24 08:00AM	Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications (GlobeNewswire)
Jan-17-24 05:53AM	Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings (InvestorPlace)
Jan-11-24 04:01PM	Bionano Announces Peer-Reviewed Publication from its Clinical Study Designed to Support OGM as Part of Standard of Care (SOC) in Genetic Disease Testing (GlobeNewswire) -7.79%
Jan-10-24 08:00AM	Bionano Announces 2024 Symposium: Four Consecutive Days of OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications (GlobeNewswire) -5.52%

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Bionano Genomics Inc

Upgrade your FINVIZ experience